Related Experiment Video
Updated: May 16, 2026

Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter
Published on: September 16, 2025
The efficiency of 0.01% topical atropine on the myopia prevention in low refractive error population with different
Chia-Yi Lee1,2,3, Shun-Fa Yang1,4, Yu-Ling Chang5
1Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Insights
Topical atropine (ATR) effectively prevented myopia progression in children with low refractive errors. The 0.01% ATR treatment showed significant reductions in spherical equivalent refraction and axial length changes, particularly in those with initial plus spherical equivalent refraction.
Area of Science:
- Ophthalmology
- Pediatric Optometry
- Myopia Control
Background:
- Myopia is a growing public health concern, especially in children.
- Low refractive errors can progress to high myopia if not managed.
- Topical atropine is explored for its potential in myopia prevention.
Purpose of the Study:
- To evaluate the efficacy of 0.01% topical atropine (ATR) in preventing myopia.
- To assess ATR's effect on refractive error and axial length in children with low refractive errors.
Main Methods:
- Retrospective cohort study involving children with low refractive error.
- Comparison between a group using 0.01% ATR and a non-ATR control group.
- Primary outcomes: changes in spherical equivalent refraction (SER) and axial length (AXL) over one year.
Main Results:
- Significantly lower SER change and AXL elongation in the ATR group versus the non-ATR group (P < 0.001).
- ATR was more effective in individuals with initial plus SER compared to minus SER (P < 0.05).
- Outdoor activity inversely correlated with myopia progression in the ATR group (P = 0.006).
Conclusions:
- 0.01% topical atropine demonstrates potential for myopia prevention in low refractive error populations.
- The effect is more pronounced in individuals with initial plus SER.
- Environmental factors like outdoor activity influence myopia progression alongside ATR treatment.
Background:
The aim of this study was to investigate the effectiveness of 0.01% topical atropine (ATR) on myopic prevention in a population with different low refractive errors.
Methods:
A retrospective cohort study was conducted on children with low refractive error. They were classified according to the application of 0.01% ATR, and 55 and 67 eyes constituted the ATR and non-ATR groups, respectively. The primary outcomes were changes in spherical equivalent refraction (SER) and axial length (AXL) after a one-year interval. Statistical analysis was carried out using the independent T test and generalized linear model.
Results:
The SER change and AXL elongation were significantly lower in the ATR group compared to the non-ATR group (P < 0.001 for both). For different initial SERs, SER and AXL progression in the individuals with plus initial SER were significantly lower than those with minus initial SER after ATR treatment (both P < 0.05). High outdoor activity was inversely correlated with myopic progression in the ATR group (P = 0.006). For the non-ATR population, young initial age, minus initial SER, and high near-work activity were related to myopic progression, while high solar exposure and high outdoor activity were inversely correlated with the development of myopic progression (all P < 0.05).
Conclusions:
Application of 0.01% ATR might relates to myopic prevention effect in a population with low refractive error, especially for plus initial SER.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Ophthalmic Drug Delivery Systems
Focusing of Light in the Eye
Glaucoma: Overview
